178 related articles for article (PubMed ID: 18948697)
1. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
Putzki N; Kumar M; Kreuzfelder E; Grosse-Wilde H; Diener HC; Limmroth V
Eur Neurol; 2009; 61(1):27-32. PubMed ID: 18948697
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
[TBL] [Abstract][Full Text] [Related]
3. Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.
Fritzsching B; Korporal M; Haas J; Krammer PH; Suri-Payer E; Wildemann B
J Neurol Sci; 2006 Dec; 251(1-2):91-7. PubMed ID: 17092518
[TBL] [Abstract][Full Text] [Related]
4. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
Korporal M; Haas J; Balint B; Fritzsching B; Schwarz A; Moeller S; Fritz B; Suri-Payer E; Wildemann B
Arch Neurol; 2008 Nov; 65(11):1434-9. PubMed ID: 19001161
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
Feger U; Luther C; Poeschel S; Melms A; Tolosa E; Wiendl H
Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
[TBL] [Abstract][Full Text] [Related]
6. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
7. Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.
Yaldizli O; Kumar M; Vago S; Kreuzfelder E; Limmroth V; Putzki N
Eur Neurol; 2009; 62(6):321-6. PubMed ID: 19752558
[TBL] [Abstract][Full Text] [Related]
8. Immunological studies of mitoxantrone in primary progressive MS.
Pelfrey CM; Cotleur AC; Zamor N; Lee JC; Fox RJ
J Neuroimmunol; 2006 Jun; 175(1-2):192-9. PubMed ID: 16644023
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients.
Chan A; Weilbach FX; Toyka KV; Gold R
Clin Exp Immunol; 2005 Jan; 139(1):152-8. PubMed ID: 15606626
[TBL] [Abstract][Full Text] [Related]
10. Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.
Putzki N; Baranwal MK; Tettenborn B; Limmroth V; Kreuzfelder E
Eur Neurol; 2010; 63(5):311-7. PubMed ID: 20453514
[TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
12. The role of regulatory T cells in multiple sclerosis.
Zozulya AL; Wiendl H
Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Chin Med J (Engl); 2008 Sep; 121(18):1781-6. PubMed ID: 19080357
[TBL] [Abstract][Full Text] [Related]
16. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
Tischner D; Weishaupt A; van den Brandt J; Müller N; Beyersdorf N; Ip CW; Toyka KV; Hünig T; Gold R; Kerkau T; Reichardt HM
Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
[TBL] [Abstract][Full Text] [Related]
18. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
de Andrés C; Aristimuño C; de Las Heras V; Martínez-Ginés ML; Bartolomé M; Arroyo R; Navarro J; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2007 Jan; 182(1-2):204-11. PubMed ID: 17157927
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Li JM; Yang Y; Zhu P; Zheng F; Gong FL; Mei YW
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):36-41. PubMed ID: 21517718
[TBL] [Abstract][Full Text] [Related]
20. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
